Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Lawrenceville, New Jersey
- Most recent report
- 8-K, filed Oct 27, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 749647
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 65
News 8 of 228
Prospectuses and Registrations 8 of 112
- S-1/A Registration statement for an offering, amended Oct 28, 2026
- S-1 Registration statement for an offering Oct 27, 2026
- S-8 Registration statement for an employee plan Jun 17, 2026
- 424B5 Prospectus supplement for an offering Mar 23, 2026
- 424B5 Prospectus supplement for an offering Dec 31, 2025
- S-8 Registration statement for an employee plan Nov 13, 2025
- 424B5 Prospectus supplement for an offering Jul 22, 2025
- 424B3 Prospectus supplement for an offering Jun 13, 2025
Proxies 8 of 28
- DEF 14A Proxy statement for a shareholder vote May 4, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 9, 2025
- PRE 14A Preliminary proxy statement May 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2022
- DEFA14A Extra proxy material Jan 26, 2022
Ownership 8 of 476
- 4 Insider reported a trade Oct 27, 2026
- 4 Insider reported a trade Oct 27, 2026
- 4 Insider reported a trade Oct 27, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Sep 28, 2026
Other 8 of 92
- DRS Draft registration statement, submitted confidentially Oct 13, 2026
- ARS Annual report sent to shareholders May 4, 2026
- UPLOAD Comment letter from SEC staff Sep 10, 2025
- CORRESP Reply to SEC staff Aug 13, 2025
- UPLOAD Comment letter from SEC staff Aug 4, 2025
- EFFECT Notice that a registration became effective Jun 13, 2025
- ARS Annual report sent to shareholders Jun 11, 2025
- CORRESP Reply to SEC staff Jun 11, 2025
Everything here comes from Imunon, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.